Simplicity Solutions’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$288K Buy
2,091
+244
+13% +$32.1K 0.01% 853
2023
Q3
$225K Sell
1,847
-118
-6% -$15.7K 0.01% 866
2023
Q2
$276K Buy
1,965
+29
+1% +$4K 0.01% 856
2023
Q1
$274K Buy
1,936
+388
+25% +$55.5K 0.01% 889
2022
Q4
$242K Sell
1,548
-295
-16% -$42.4K 0.03% 554
2022
Q3
$226K Buy
+1,843
New +$243K 0.03% 553
2020
Q3
Sell
-3,492
Closed -$398K 868
2020
Q2
$398K Buy
+3,492
New +$370K 0.01% 675
2019
Q3
Sell
-3,553
Closed -$362K 728
2019
Q2
$362K Buy
+3,553
New +$341K 0.02% 444
2018
Q4
Sell
-2,870
Closed -$310K 652
2018
Q3
$310K Buy
2,870
+1,031
+56% +$113K 0.02% 366
2018
Q2
$202K Buy
+1,839
New +$192K 0.01% 471

Other funds holding DGX

Simplicity Solutions's DGX Position: Q4 2023 in Review

Simplicity Solutions increased its Quest Diagnostics (DGX) stake by 13% in Q4 2023, buying an estimated $32.1K and bringing the position to 2,091 shares worth $288K. The position accounts for 0.01% of the portfolio, ranked #853.

Simplicity Solutions first reported a position in DGX in Q2 2018 and has held it in 10 quarters since. The position peaked at $398K in Q2 2020. 826 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

  • Simplicity Solutions held 2,091 shares of Quest Diagnostics worth $288K as of Q4 2023.
  • Simplicity Solutions bought 244 Quest Diagnostics shares in Q4 2023, an estimated $32.1K.
  • Quest Diagnostics made up 0.01% of Simplicity Solutions's portfolio in Q4 2023, its #853 holding.
  • Simplicity Solutions first reported a position in Quest Diagnostics in Q2 2018 and has held it in 10 quarters since.
  • Simplicity Solutions's Quest Diagnostics position peaked at $398K in Q2 2020.
  • 826 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.